408 related articles for article (PubMed ID: 33441073)
1. Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review.
Ramachandran AK; Das S; Joseph A
Curr Neuropharmacol; 2021; 19(10):1688-1700. PubMed ID: 33441073
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
5. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
6. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
Xu Y; Zhuang Y; Kang L
Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
[TBL] [Abstract][Full Text] [Related]
7. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
8. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
Ahmadi S; Khaledi S
Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
[TBL] [Abstract][Full Text] [Related]
9. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
10. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
11. Neurological associations of COVID-19.
Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
[TBL] [Abstract][Full Text] [Related]
12. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B
Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076
[TBL] [Abstract][Full Text] [Related]
13. The neurological manifestations of COVID-19: a review article.
Niazkar HR; Zibaee B; Nasimi A; Bahri N
Neurol Sci; 2020 Jul; 41(7):1667-1671. PubMed ID: 32483687
[TBL] [Abstract][Full Text] [Related]
14. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight.
Kumar R; Harilal S; M S; Pappachan LK; P R R; Mathew B
Comb Chem High Throughput Screen; 2022; 25(5):763-767. PubMed ID: 34353250
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations of COVID-19: available evidences and a new paradigm.
Khatoon F; Prasad K; Kumar V
J Neurovirol; 2020 Oct; 26(5):619-630. PubMed ID: 32839951
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
18. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
Galassi G; Marchioni A
Acta Neurol Belg; 2020 Oct; 120(5):1067-1075. PubMed ID: 32696312
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Neurology: An Emerging Association.
Gupta A; Yadav P; Kumar D
Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
[TBL] [Abstract][Full Text] [Related]
20. Review article on COVID-19 and Guillain-Barré syndrome.
Patnaik UJ
Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
